Subscribe to the newsletter

Publications

Latest publications

Load previous publications
  • November 14, 2017

    Synthetic human leukemia models: towards precision medicine.

    Cellot S, Wilhelm B, Barabé F
    Oncotarget 2017-11-14 ;8( 57 ):96480-96481

  • November 14, 2017

    Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.

    Corrêa MF, Barbosa ÁJR, Teixeira LB, Duarte DA, Simões SC, Parreiras-E-Silva LT, Balbino AM, Landgraf RG, Bouvier M, Costa-Neto CM, Fernandes JPS
    Front Pharmacol 2017-11-14 ;8:825

  • November 7, 2017

    The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.

    Zahreddine HA, Culjkovic-Kraljacic B, Emond A, Pettersson F, Midura R, Lauer M, Del Rincon S, Cali V, Assouline S, Miller WH, Hascall V, Borden K
    Elife 2017-11-07 ;6:

  • November 1, 2017

    Identification of cross talk between SUMOylation and ubiquitylation using a sequential peptide immunopurification approach.

    McManus FP, Lamoliatte F, Thibault P
    Nat Protoc 2017-11-01 ;12( 11 ):2342-2358

  • November 1, 2017

    Study of Methylene Blue Ototoxicity in the Guinea Pig.

    Belhassen S, Alzahrani M, Nader ME, Gaboury L, Saliba I
    J Clin Med Res 2017-11-01 ;9( 11 ):900-906

  • November 1, 2017

    Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.

    Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, Rammensee HG, Melief C, Thibault P, Perreault C, Pol J, Zitvogel L, Senovilla L, Kroemer G
    Immunol. Rev. 2017-11-01 ;280( 1 ):165-174

  • November 1, 2017

    WD40 repeat domain proteins: a novel target class?

    Schapira M, Tyers M, Torrent M, Arrowsmith CH
    Nat Rev Drug Discov 2017-11-01 ;16( 11 ):773-786

  • November 1, 2017

    PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.

    Chen L, Yuan Y, Kar S, Kanchi MM, Arora S, Kim JE, Koh PF, Yousef E, Samy RP, Shanmugam MK, Tan TZ, Shin SW, Arfuso F, Shen HM, Yang H, Goh BC, Park JI, Gaboury L, Lobie PE, Sethi G, Lim LHK, Kumar AP
    Mol. Cancer Ther. 2017-11-01 ;16( 11 ):2528-2542

Load more publications